Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
LiqTech International Inc is a pollution & treatment controls business based in the US. LiqTech International shares (LIQT) are listed on the NASDAQ and all prices are listed in US Dollars. LiqTech International employs 112 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$5.55|
|52-week range||$4.69 - $12.70|
|50-day moving average||$5.57|
|200-day moving average||$6.65|
|Wall St. target price||$10.50|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.61|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-13)||-9.76%|
|1 month (2021-09-24)||-1.77%|
|3 months (2021-07-23)||-14.88%|
|6 months (2021-04-23)||-28.11%|
|1 year (2020-10-23)||-30.01%|
|2 years (2019-10-24)||-31.99%|
|3 years (2018-10-24)||347.58%|
|5 years (2016-10-24)||640.00%|
Valuing LiqTech International stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of LiqTech International's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
LiqTech International's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $1.4 million.
The EBITDA is a measure of a LiqTech International's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$15.6 million|
|Gross profit TTM||$2.1 million|
|Return on assets TTM||-15.5%|
|Return on equity TTM||-58.2%|
|Market capitalisation||$128.5 million|
TTM: trailing 12 months
There are currently 1.3 million LiqTech International shares held short by investors – that's known as LiqTech International's "short interest". This figure is 1% up from 1.3 million last month.
There are a few different ways that this level of interest in shorting LiqTech International shares can be evaluated.
LiqTech International's "short interest ratio" (SIR) is the quantity of LiqTech International shares currently shorted divided by the average quantity of LiqTech International shares traded daily (recently around 97699.025487256). LiqTech International's SIR currently stands at 13.34. In other words for every 100,000 LiqTech International shares traded daily on the market, roughly 13340 shares are currently held short.
However LiqTech International's short interest can also be evaluated against the total number of LiqTech International shares, or, against the total number of tradable LiqTech International shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case LiqTech International's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 LiqTech International shares in existence, roughly 60 shares are currently held short) or 0.0952% of the tradable shares (for every 100,000 tradable LiqTech International shares, roughly 95 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against LiqTech International.
Find out more about how you can short LiqTech International stock.
We're not expecting LiqTech International to pay a dividend over the next 12 months.
LiqTech International's shares were split on a 1:4 basis on 8 April 2019. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your LiqTech International shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for LiqTech International shares which in turn could have impacted LiqTech International's share price.
Over the last 12 months, LiqTech International's shares have ranged in value from as little as $4.69 up to $12.7. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while LiqTech International's is 0.7016. This would suggest that LiqTech International's shares are less volatile than average (for this exchange).
LiqTech International, Inc. , a clean technology company, designs, develops, produces, markets, and sells automated filtering systems, and ceramic silicon carbide liquid applications and diesel particulate air filters in the United States, Canada, Europe, Asia, and South America. The company manufactures and sells ceramic silicon carbide filters and membranes for liquid filtration under the LiqTech, Cometas, and Provital brand names, which are used for the filtration of produced water, pre-filtration of reverse osmosis drinking water, industrial applications, producing clean drinking water, and pool and spa water, as well as marine scrubber wash water. It also offers diesel particulate filters for exhaust emission control solutions to the verified retrofit and the original equipment manufacturer market; and plastics, which provide machined and welded plastic parts for the prepress, UV, and aquaculture market segments. LiqTech International, Inc. sells its products primarily to industrial customers through direct sales, systems integrators, distributors, agents, and partners. The company was formerly known as Blue Moose Media, Inc.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.